Iovance Biotherapeutics, Inc.IOVANASDAQ
Loading
Enterprise value to EBITDA ratio
Latest
-2.41
↑ 70% vs avg
Percentile
P86
Within normal range
Streak
1 yr
Consecutive growthExpanding
Average
-8.13
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| 2025 | -2.41 | +59.4% |
| 2024 | -5.94 | -35.5% |
| 2023 | -4.38 | -89.9% |
| 2022 | -2.31 | +74.0% |
| 2021 | -8.89 | +63.8% |
| 2020 | -24.55 | -35.2% |
| 2019 | -18.15 | -185.9% |
| 2018 | -6.35 | -53.7% |
| 2017 | -4.13 | +1.4% |
| 2016 | -4.19 | - |